Sunday, February 03, 2008

Eli Lilly settles 900 more claims over Antipsychotic Zyprexa
Indianapolis Star
Eli Lilly settles 900 more claims over Zyprexa January 24, 2008
INDIANAPOLIS -- Eli Lilly and Co. has settled another 900 personal-
injury claims against its antipsychotic drug Zyprexa, including five set
to go to court next month, thus avoiding what would have been the first
trial in the U.S. The Indianapolis drug maker confirmed the settlement
Wednesday but declined to reveal the amount. With the latest agreements,
Lilly has settled more than 25,000 claims, leaving about 1,100
unsettled. Many of the plaintiffs have claimed Lilly underplayed the
drug's side effects, including weight gain and elevated blood sugar.
Lilly has set aside $1.2 billion to pay claims.


More on Zyprexa below...

Video: Zyprexa Drug Rep

Video - St. Petersburg Times reporter on Zyprexa:


St. Petersburg Times
Zyprexa in court
December 16, 2007
Individual claims: Over the past two years, Eli Lilly has paid $1.2-
billion to settle lawsuits from some 30,000 people, most of whom claim
Zyprexa caused them to develop diabetes. Hundreds more cases are

State claims: Nine states have sued Eli Lilly claiming the company
promoted Zyprexa for off-label uses and downplayed its risks. Each state
wants to be reimbursed hundreds of millions of dollars in Medicaid
dollars paid for Zyprexa.

Florida has not sued and won't comment, though Eli Lilly has said that
it received a subpoena in 2005 from the state's Medicaid Fraud Control
Unit, seeking documents related to the sales, marketing and promotional
practices of Zyprexa.

Daytona Beach News Journal
January 10, 2008
Florida undecided as states sue over costly drug program "Our office is
aware of concerns with antipsychotics in Florida's Medicaid program but
we cannot acknowledge nor provide any information pertaining to ongoing
criminal investigations," said Sandi Copes, a spokeswoman with the
Florida Attorney General's office. Florida Medicaid records show the
number of children -- some just months old
-- who were prescribed the drugs went from 9,364 seven years ago to
18,137 in 2006. No records for privately insured patients are available.
"The situation is out of control," said David Cohen, a professor at
Florida International University who has been studying the use of
antipsychotics since 1983. While no long-term studies have been done on
the effects the drugs have on children, there is evidence children on
the drugs face greater risks of diabetes, hyperglycemia and extreme
weight gain, Cohen said. Parent, Richard Davis, said he watched in
horror as his daughter Ciara, then 6, gained 40 pounds, developed
breasts and had uncontrollable tongue and facial movements.
"Those drugs were killing her," Davis said. Over his objections, he said
Ciara was given antipsychotics by her mother and while in foster care. A
court-appointed guardian also noted the effects in an August
2003 report, describing a visit in which Ciara "never once kept her
tongue in her mouth." Ciara, now 11, was taken off the drugs after
about a year, her father said, and she quickly dropped the added weight.
Editorial: Drugs for children? Prescriptions of anti-psychotics
troubling January 16, 2008 ... And a state struggling to keep up with
rapid changes that have pushed Medicaid costs for powerful
anti-psychotic drugs from $9
million seven years ago to almost $30 million in 2006. Something
doesn't add up. Do all these children need the drugs they're being
prescribed? ... the trend is disturbing. Other states are already
pushing hard for answers, and Florida should join in. The drugs in
question are known as atypical anti-psychotics and include Risperdal,
Abilify, Geodon and Seroquel ... Twenty-six states are exploring legal
action against drug companies for unfair trade practices or consumer-
protection violations (Florida is one of them; the Attorney General's
Medicaid Fraud Control Unit served drug manufacturer Eli Lilly with a
request in 2005 for information regarding its marketing of the drug
Zyprexa.) Other states are being more aggressive; several have actually
filed suit seeking to reclaim some of the millions spent on these drugs.

No comments: